Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling

Shiyong Liu, Gordon Liu, David M Bishai, Judy C. Xu, Hong Xue, Youfa Wang

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

The growing global diabetes epidemic is a serious public health problem. We developed a system dynamic model to study the cost-effectiveness of different diabetes treatment options. According to existing literature, we estimated dynamic costs and changes of hemoglobin A1c levels of two first-line monotherapies and a hypothetical innovation therapy for glycemic control over a 15-year horizon. Incremental cost-effectiveness ratios were expressed as dollars per HbA1c decrement from perspectives of the patient, insurance-payer, and society. Simulation results showed that better adherence with a more expensive and efficacious drug results in better control of HbA1c and cost-saving in the long-run. The results also showed that the cost-effectiveness ratio varied with patients' pre-determined out-of-pocket payment for health expenditure. The higher the rate of their out-of-pocket payment for extra health care expenditure to their household income, the more cost-effective it is for the innovative drug from the perspectives of the patient, insurance-payer, and society.

Original languageEnglish (US)
Title of host publicationWSC 2018 - 2018 Winter Simulation Conference
Subtitle of host publicationSimulation for a Noble Cause
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages2577-2588
Number of pages12
ISBN (Electronic)9781538665725
DOIs
StatePublished - Jan 31 2019
Event2018 Winter Simulation Conference, WSC 2018 - Gothenburg, Sweden
Duration: Dec 9 2018Dec 12 2018

Publication series

NameProceedings - Winter Simulation Conference
Volume2018-December
ISSN (Print)0891-7736

Conference

Conference2018 Winter Simulation Conference, WSC 2018
CountrySweden
CityGothenburg
Period12/9/1812/12/18

Fingerprint

Cost-effectiveness
Diabetes
Dynamic Modeling
Cost effectiveness
Medical problems
System Modeling
System Dynamics
Dynamical systems
Insurance
Drugs
Costs
Hemoglobin
Public Health
Public health
Long-run
Health care
Healthcare
Therapy
Horizon
Dynamic models

ASJC Scopus subject areas

  • Software
  • Modeling and Simulation
  • Computer Science Applications

Cite this

Liu, S., Liu, G., Bishai, D. M., Xu, J. C., Xue, H., & Wang, Y. (2019). Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling. In WSC 2018 - 2018 Winter Simulation Conference: Simulation for a Noble Cause (pp. 2577-2588). [8632264] (Proceedings - Winter Simulation Conference; Vol. 2018-December). Institute of Electrical and Electronics Engineers Inc.. https://doi.org/10.1109/WSC.2018.8632264

Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling. / Liu, Shiyong; Liu, Gordon; Bishai, David M; Xu, Judy C.; Xue, Hong; Wang, Youfa.

WSC 2018 - 2018 Winter Simulation Conference: Simulation for a Noble Cause. Institute of Electrical and Electronics Engineers Inc., 2019. p. 2577-2588 8632264 (Proceedings - Winter Simulation Conference; Vol. 2018-December).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Liu, S, Liu, G, Bishai, DM, Xu, JC, Xue, H & Wang, Y 2019, Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling. in WSC 2018 - 2018 Winter Simulation Conference: Simulation for a Noble Cause., 8632264, Proceedings - Winter Simulation Conference, vol. 2018-December, Institute of Electrical and Electronics Engineers Inc., pp. 2577-2588, 2018 Winter Simulation Conference, WSC 2018, Gothenburg, Sweden, 12/9/18. https://doi.org/10.1109/WSC.2018.8632264
Liu S, Liu G, Bishai DM, Xu JC, Xue H, Wang Y. Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling. In WSC 2018 - 2018 Winter Simulation Conference: Simulation for a Noble Cause. Institute of Electrical and Electronics Engineers Inc. 2019. p. 2577-2588. 8632264. (Proceedings - Winter Simulation Conference). https://doi.org/10.1109/WSC.2018.8632264
Liu, Shiyong ; Liu, Gordon ; Bishai, David M ; Xu, Judy C. ; Xue, Hong ; Wang, Youfa. / Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling. WSC 2018 - 2018 Winter Simulation Conference: Simulation for a Noble Cause. Institute of Electrical and Electronics Engineers Inc., 2019. pp. 2577-2588 (Proceedings - Winter Simulation Conference).
@inproceedings{65153e2afd4f4230af05a934f88c3bed,
title = "Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling",
abstract = "The growing global diabetes epidemic is a serious public health problem. We developed a system dynamic model to study the cost-effectiveness of different diabetes treatment options. According to existing literature, we estimated dynamic costs and changes of hemoglobin A1c levels of two first-line monotherapies and a hypothetical innovation therapy for glycemic control over a 15-year horizon. Incremental cost-effectiveness ratios were expressed as dollars per HbA1c decrement from perspectives of the patient, insurance-payer, and society. Simulation results showed that better adherence with a more expensive and efficacious drug results in better control of HbA1c and cost-saving in the long-run. The results also showed that the cost-effectiveness ratio varied with patients' pre-determined out-of-pocket payment for health expenditure. The higher the rate of their out-of-pocket payment for extra health care expenditure to their household income, the more cost-effective it is for the innovative drug from the perspectives of the patient, insurance-payer, and society.",
author = "Shiyong Liu and Gordon Liu and Bishai, {David M} and Xu, {Judy C.} and Hong Xue and Youfa Wang",
year = "2019",
month = "1",
day = "31",
doi = "10.1109/WSC.2018.8632264",
language = "English (US)",
series = "Proceedings - Winter Simulation Conference",
publisher = "Institute of Electrical and Electronics Engineers Inc.",
pages = "2577--2588",
booktitle = "WSC 2018 - 2018 Winter Simulation Conference",

}

TY - GEN

T1 - Evaluating cost-effectiveness of treatment options for diabetes patients using system dynamics modeling

AU - Liu, Shiyong

AU - Liu, Gordon

AU - Bishai, David M

AU - Xu, Judy C.

AU - Xue, Hong

AU - Wang, Youfa

PY - 2019/1/31

Y1 - 2019/1/31

N2 - The growing global diabetes epidemic is a serious public health problem. We developed a system dynamic model to study the cost-effectiveness of different diabetes treatment options. According to existing literature, we estimated dynamic costs and changes of hemoglobin A1c levels of two first-line monotherapies and a hypothetical innovation therapy for glycemic control over a 15-year horizon. Incremental cost-effectiveness ratios were expressed as dollars per HbA1c decrement from perspectives of the patient, insurance-payer, and society. Simulation results showed that better adherence with a more expensive and efficacious drug results in better control of HbA1c and cost-saving in the long-run. The results also showed that the cost-effectiveness ratio varied with patients' pre-determined out-of-pocket payment for health expenditure. The higher the rate of their out-of-pocket payment for extra health care expenditure to their household income, the more cost-effective it is for the innovative drug from the perspectives of the patient, insurance-payer, and society.

AB - The growing global diabetes epidemic is a serious public health problem. We developed a system dynamic model to study the cost-effectiveness of different diabetes treatment options. According to existing literature, we estimated dynamic costs and changes of hemoglobin A1c levels of two first-line monotherapies and a hypothetical innovation therapy for glycemic control over a 15-year horizon. Incremental cost-effectiveness ratios were expressed as dollars per HbA1c decrement from perspectives of the patient, insurance-payer, and society. Simulation results showed that better adherence with a more expensive and efficacious drug results in better control of HbA1c and cost-saving in the long-run. The results also showed that the cost-effectiveness ratio varied with patients' pre-determined out-of-pocket payment for health expenditure. The higher the rate of their out-of-pocket payment for extra health care expenditure to their household income, the more cost-effective it is for the innovative drug from the perspectives of the patient, insurance-payer, and society.

UR - http://www.scopus.com/inward/record.url?scp=85062639468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062639468&partnerID=8YFLogxK

U2 - 10.1109/WSC.2018.8632264

DO - 10.1109/WSC.2018.8632264

M3 - Conference contribution

AN - SCOPUS:85062639468

T3 - Proceedings - Winter Simulation Conference

SP - 2577

EP - 2588

BT - WSC 2018 - 2018 Winter Simulation Conference

PB - Institute of Electrical and Electronics Engineers Inc.

ER -